This inventor holds 1 USPTO granted patent. Top assignee: Roche Diagnostics Gmbh. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Yorn Schmidt: Innovator in Oligodendrocyte Regeneration
Introduction
Yorn Schmidt is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical science, particularly in the regeneration of oligodendrocytes, which are crucial for the proper functioning of the nervous system.
Latest Patents
Yorn Schmidt holds a patent for a method titled "In vivo regeneration of oligodendrocytes by bolus injection of NGF&bgr;." This innovative approach addresses diseases such as multiple sclerosis by administering human β nerve growth factor (NGF-β) through bolus injections. The treatment protocol involves 1-10 bolus injections, with a dosage ranging from 0.05 to 5.0 µg/kg body weight, administered at intervals of 1 to 21 days.
Career Highlights
Yorn Schmidt is currently employed at Roche Diagnostics GmbH, where he continues to advance his research and development efforts. His work focuses on innovative solutions that can improve patient outcomes in neurological disorders.
Collaborations
Some of Yorn Schmidt's notable coworkers include Ilse Bartke and Jürgen Unger. Their collaborative efforts contribute to the ongoing research and development in the field of oligodendrocyte regeneration.
Conclusion
Yorn Schmidt's work in the regeneration of oligodendrocytes represents a significant advancement in medical science. His innovative patent and contributions to Roche Diagnostics GmbH highlight his commitment to improving treatments for neurological diseases.